Ikarian Capital, LLC Blueprint Medicines Corp Transaction History
Ikarian Capital, LLC
- $714 Million
- Q1 2025
A detailed history of Ikarian Capital, LLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Ikarian Capital, LLC holds 113,904 shares of BPMC stock, worth $11.6 Million. This represents 1.41% of its overall portfolio holdings.
Number of Shares
113,904
Previous 169,374
32.75%
Holding current value
$11.6 Million
Previous $14.8 Million
31.76%
% of portfolio
1.41%
Previous 2.44%
Shares
5 transactions
Others Institutions Holding BPMC
# of Institutions
390Shares Held
68.6MCall Options Held
1.54MPut Options Held
1.08M-
Black Rock Inc. New York, NY6.65MShares$675 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.64MShares$674 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.42MShares$550 Million0.06% of portfolio
-
Avoro Capital Advisors LLC New York, NY3.85MShares$391 Million5.51% of portfolio
-
Wellington Management Group LLP Boston, MA3.07MShares$312 Million0.05% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $6.06B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...